ClinicalTrials.gg
Status unknownNCT03509077CAPAUpdated Apr 18, 2019

Study of Addiction Criteria in the Elderly

An observational study in Depressive Disorder, sponsored by University Hospital, Toulouse. Status unknown at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2019-04-18.

Sponsored by University Hospital, Toulouse · Observational

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
120
Ages
65 Years and older
Sex
All
01

Study summary

Patients over 65 years old who are exposed to alcohol or benzodiazepines will be recruited through the Fragility Assessment and Addictions Prevention Day Hospital, the Addiction Service and the Geriatric Post-Emergency Department. Toulouse University Hospital.

The investigators will study descriptively the frequency of substance use disorder and the frequency of DSM-5 criteria associated with this diagnosis in a population of elderly subjects.

Read the detailed description

The hypothesis of this research is that some of the DSM-5 criteria for substance use disorder are more appropriate than others in people over 65 years of age. This study therefore aims to describe the frequency of the DSM-5 criteria for the substance use disorder in a population over 65 years of age and to link it secondarily to the severity of the addiction.

The study is a descriptive study of a population of subjects over 65 years old. It aims to search for addiction criteria in this population by formulating the hypothesis of an addictive vulnerability relating to certain risk factors.

To sensitize the detection of criteria, we chose among older subjects those who are most at risk because they are more exposed to the vulnerability factor relative to this population (physical disability, loss of autonomy, loneliness).

02

Conditions studied

  • Depressive Disorder

Keywords

  • geriatric
  • addiction
03

In context

Depressive Disorder

4,847 studies on the registry are indexed under Depressive Disorder; 509 are open to participants now.

This study's planned enrollment of 120 is below the median of 150 across 656 observational studies indexed under Depressive Disorder.

Browse Depressive Disorder studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 805 studies on the registry; 215 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Three groups of patients will be recruited in three departments of the University Hospital of Toulouse:

  1. Patients meeting the criteria for frailty will be recruited to the Fragility Assessment and Addiction Prevention Day Hospital.
  2. Patients over 65, addicts and consultant in a specialized service.
  3. Patients who have decompensated their fragility criteria will be recruited from the geriatric post-emergency department of Toulouse University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To be over 65
  • Have given your non-oral opposition to participate in research
  • Mini-Mental State Examination (MMSE) greater than or equal to 24
  • Be part of one of the 3 inclusion services of the University Hospital of Toulouse
  • For 12 months, have daily consumption of benzodiazepine (at least once a day) and / or have excessive alcohol consumption as recommended by the American Geriatric Society (more than one unit of alcohol per day) ).

Exclusion criteria

Exclusion Criteria:

  • Patient refusing to participate in the study
  • MMSE less than 24
  • Acute decompensation of a psychiatric disorder
  • Impossibility to understand or speak French
  • Patient under the protection of justice
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The number of DSM-5 criteria

    The number of DSM-5 criteria for substance use disorder in the patient assessment. The number of DSM-5 criteria is a method of problematic substance use leading to clinically significant impairment or impairment characterized by the presence of at least two of the following manifestations over a 12-month period

    Time frame: 1 hour

Secondary outcomes

  1. The Mini-GDS : a screening tool

    The diagnosis of depression will be made using a screening tool, the Mini-GDS, performed in routine clinical practice as part of the assessment at the day hospital for frailty and addiction prevention. The Mini-GDS includes 4 items rated at one point depending on the answer. A higher score 1 makes it possible to suspect the existence of a depression.

    Time frame: 1 hour

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03509077
Responsible party
Sponsor
First posted
Apr 26, 2018
Start date
Jun 19, 2018
Primary completion
Jun 19, 2019 (estimated)
Completion
Jun 19, 2019 (estimated)
Last update
Apr 18, 2019

Study contacts

Juliette Salles, MD
Contact
salles.j@chu-toulouse.fr
05 34 55 75 24 ext. 33
Isabelle Olivier, PhD
Contact
olivier.i@chu-toulouse.fr
05 61 77 70 51 ext. 33
Juliette Salles, MD
principal investigator · University Hospital, Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion